Ed Duckworth
About Ed Duckworth
Ed Duckworth is a Senior Scientist in Biochemistry at KalVista Pharmaceuticals, Inc. in Porton, England, where he leads a team focused on biochemical profiling to support drug discovery efforts.
Work at KalVista Pharmaceuticals
Ed Duckworth has been employed at KalVista Pharmaceuticals, Inc. since 2020, serving as a Senior Scientist in Biochemistry. His role involves leading a team of three scientists dedicated to biochemical profiling aimed at enhancing the drug discovery process. Duckworth is responsible for conducting in-depth compound profiling and pharmacokinetic/pharmacodynamic (PKPD) analysis of clinical samples. He also contributes to the progression of compounds beyond the laboratory, engaging in activities such as publications, regulatory filings, and project management.
Previous Experience in Biochemistry
Prior to his current position, Ed Duckworth worked at KalVista Pharmaceuticals as a Research Biochemist from 2017 to 2020. He also held the position of Inhalation Scientist at Nanopharm Ltd for five months in 2016. Earlier in his career, he completed a Lab Management Internship at VWR in 2015 and an internship at the Health Protection Agency in 2012. These roles provided him with a diverse range of experiences in biochemistry and laboratory management.
Education and Expertise
Ed Duckworth earned his Bachelor’s Degree in Biochemistry from the University of Bristol, where he studied from 2012 to 2016. He also completed his high school education at Dauntsey's School from 2006 to 2012. His academic background has equipped him with specific expertise in the contact system and coagulation within the field of biochemistry, which he applies in his current research and development efforts.
Skills in Drug Discovery
Duckworth possesses significant hands-on experience with hit to lead projects, including assay development and high throughput screening. His skills in these areas are critical to the drug discovery process at KalVista Pharmaceuticals. He applies his knowledge of biochemical profiling and PKPD analysis to advance the understanding and development of therapeutic compounds.